241 related articles for article (PubMed ID: 30165365)
21. A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
Lai J; Wang H; Pan Z; Su F
Aging (Albany NY); 2019 Jan; 11(2):649-662. PubMed ID: 30696800
[TBL] [Abstract][Full Text] [Related]
22. Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer:A pooled analysis of individual studies.
Zhou Q; Zuo MZ; He Z; Li HR; Li W
Int J Biol Markers; 2018 Apr; ():1724600818766500. PubMed ID: 29683066
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of MiR-365 as a novel indicator to assess the progression and metastasis of hepatocellular carcinoma.
He RQ; Pang YY; Zhang R; Liang HW; Li CY; Ma J; Feng ZB; Peng ZG; Chen G
Int J Clin Exp Pathol; 2017; 10(9):9164-9176. PubMed ID: 31966789
[TBL] [Abstract][Full Text] [Related]
24. The Diagnostic Value of Circulating miR-29 Family for Digestive System Malignancies: A Meta-Analysis.
Zou S; Chen F; Zhang L; Liu C; Chen H
Lab Med; 2024 Jan; 55(1):1-7. PubMed ID: 37172311
[TBL] [Abstract][Full Text] [Related]
25. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
26. Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression.
Frampton AE; Castellano L; Colombo T; Giovannetti E; Krell J; Jacob J; Pellegrino L; Roca-Alonso L; Funel N; Gall TM; Ahmad R; Habib NA; Knösel T; Stebbing J; Jiao LR
Lancet; 2015 Feb; 385 Suppl 1():S37. PubMed ID: 26312859
[TBL] [Abstract][Full Text] [Related]
27. The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis.
Mukhopadhyay D; Cocco P; Orrù S; Cherchi R; De Matteis S
Pulmonology; 2024 Feb; ():. PubMed ID: 38402124
[TBL] [Abstract][Full Text] [Related]
28. Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis.
Yau TO; Tang CM; Harriss EK; Dickins B; Polytarchou C
Sci Rep; 2019 Jul; 9(1):9491. PubMed ID: 31263200
[TBL] [Abstract][Full Text] [Related]
29. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract][Full Text] [Related]
30. Blood miRNAs as Potential Diagnostic Biomarkers for Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Li X; Fu G; Zhang C; Wu Y; Guo H; Li W; Zeng X
Int J Chron Obstruct Pulmon Dis; 2024; 19():981-993. PubMed ID: 38715982
[TBL] [Abstract][Full Text] [Related]
31. Blood-based circulating microRNAs as diagnostic biomarkers for subclinical carotid atherosclerosis: A systematic review and meta-analysis with bioinformatics analysis.
Witarto BS; Visuddho V; Aldian FM; Atmaja MSS; Ariyanto MV; Witarto AP; Wungu CDK; Susilo H; Alsagaff MY; Rohman MS
Diabetes Metab Syndr; 2023 Oct; 17(10):102860. PubMed ID: 37742360
[TBL] [Abstract][Full Text] [Related]
32. Blood miRNAs miR-549a, miR-552, and miR-592 serve as potential disease-specific panels to diagnose colorectal cancer.
Akbar S; Mashreghi S; Kalani MR; Valanik A; Ahmadi F; Aalikhani M; Bazi Z
Heliyon; 2024 Apr; 10(7):e28492. PubMed ID: 38571665
[TBL] [Abstract][Full Text] [Related]
33. Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis.
Aushev VN; Lee E; Zhu J; Gopalakrishnan K; Li Q; Teitelbaum SL; Wetmur J; Degli Esposti D; Hernandez-Vargas H; Herceg Z; Parada H; Santella RM; Gammon MD; Chen J
Clin Cancer Res; 2018 Feb; 24(3):581-591. PubMed ID: 29138345
[No Abstract] [Full Text] [Related]
34. miRNAs target databases: developmental methods and target identification techniques with functional annotations.
Singh NK
Cell Mol Life Sci; 2017 Jun; 74(12):2239-2261. PubMed ID: 28204845
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the Prognostic Value of microRNA-22 in Leukemia Patients.
Xia J; Xu D; Qin Y; Wan F; Ren Y; Bu C; Li T
Technol Cancer Res Treat; 2023; 22():15330338231212309. PubMed ID: 37942522
[No Abstract] [Full Text] [Related]
36. miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.
Ravegnini G; Gorini F; Coada CA; De Leo A; de Biase D; Di Costanzo S; De Crescenzo E; Coschina E; Monesmith S; Bernante P; Garelli S; Balsamo F; Hrelia P; De Iaco P; Angelini S; Perrone AM
Cancer Sci; 2024 Mar; 115(3):883-893. PubMed ID: 38196275
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Xi T; Zhang G
PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer.
Nøst TH; Skogholt AH; Urbarova I; Mjelle R; Paulsen EE; Dønnem T; Andersen S; Markaki M; Røe OD; Johansson M; Johansson M; Grønberg BH; Sandanger TM; Saetrom P
Mol Oncol; 2023 Feb; 17(2):312-327. PubMed ID: 36337027
[TBL] [Abstract][Full Text] [Related]
39. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review.
Khan IA; Saraya A
J Gastrointest Cancer; 2023 Sep; 54(3):720-730. PubMed ID: 36322366
[TBL] [Abstract][Full Text] [Related]
40. Systemic analysis of the prognostic significance and interaction network of miR-26b-3p in cholangiocarcinoma.
Yan X; Hu Z; Li X; Liang J; Zheng J; Gong J; Hu K; Sui X; Li R
Appl Biochem Biotechnol; 2023 Nov; ():. PubMed ID: 37914963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
